XML 23 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash Flows from Operating Activities    
Net loss $ (21,862,716) $ (9,240,409)
Net income/(loss) from discontinued operations (10,559,963) 1,786,737
Net loss from continuing operations (11,302,753) (11,027,146)
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:    
Depreciation and amortization 3,013,986 2,319,508
Gain/(loss) on disposal of property & equipment 471,019 (2,094,621)
Change in allowance for doubtful accounts 408,000
Share-based compensation 622,232
Interest expense paid in equity shares 1,590,374 109,144
Income tax benefit (1,335,584) (2,861,672)
Interest expense on convertible debt 593,975
Loss on equity interests 342,776 1,214,659
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:    
Accounts receivable 3,082,635 3,679,052
Accounts receivable - related party (61,799)
Inventory 1,341,569 (80,952)
Prepaid expenses and other current assets (132,510) 358,606
Other assets (27,418) 203,141
Other liabilities 1,221,549
Accounts payable (2,114,250) (1,735,352)
Deposits from customers (17,545) 50,619
Accrued expenses (493,921) (3,988,468)
Deferred revenue 228,024
Income taxes payable (124,505)
Net cash used by operating activities - continuing operations (3,571,616) (13,005,012)
Net cash provided by operating activities - discontinued operations 7,507,090 10,523,481
Net cash provided by operating activities 3,935,474 (2,481,531)
Cash Flows from Investing Activities    
Purchase of property and equipment (1,659,480) (12,207,320)
Refund on property and equipment 14,000
Purchase of marketable securities (398,291)
Net cash used by investing activities - continuing operations (2,043,771) (12,207,320)
Net cash provided by investing activities - discontinued operations 8,883,541
Net cash provided by investing activities 6,839,770 (12,207,320)
Cash Flows from Financing Activities    
Proceeds from notes payable 2,595,000 4,025,000
Payments on notes payable (414,859) (564,728)
Issuance of notes receivable (3,300,289)
Payments on bank loans (1,440,535) (537,570)
Proceeds from at-the-market offerings 957,784 1,650,000
Expenses on at-the-market offerings (41,438) (147,500)
Proceeds from the issuance of Series B Preferred Stock 500,000
Expenses from the issuance of Series B Preferred Stock (25,000)
Settlement of Series B Preferred Stock in Cash (273,092)
Revolving line of credit (925,124) (796,841)
Payments on capital lease obligations (24,286) (4,270)
Net cash provided/(used) by financing activities - continuing operations (2,391,839) 3,624,091
Net cash provided/(used) by financing activities - discontinued operations (9,465,508) 1,726,748
Net cash provided/(used) by financing activities (11,857,347) 5,350,839
Effect of currency translation 1,624,253 (320,805)
Net decrease in cash (1,082,103) (9,338,012)
Cash beginning of period 2,315,935 11,974,752
Cash end of period 2,858,085 2,315,935
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 672,637 259,317
Cash paid during the period for income taxes 162,871 852,071
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Investment in Vicon Technologies 300,000 2,913,930
Payment of convertible notes in common stock 220,000
Stock issued to pay notes payable 5,047,569 1,054,144
Acquisition of equipment through capital leases 71,069
Dividends paid in equity shares $ 1,965,500 $ 915,080